Welcome to our dedicated page for Azenta news (Ticker: $AZTA), a resource for investors and traders seeking the latest updates and insights on Azenta stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Azenta's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Azenta's position in the market.
Azenta, Inc. (Nasdaq: AZTA) announced a CEO succession plan with CEO Dr. Stephen Schwartz retiring after over 14 years of service. The Board is actively searching for a successor with the help of a leading executive search firm. Dr. Schwartz expressed pride in Azenta's transformation into a leading life sciences business and supports a smooth transition to the new CEO. Azenta also reported its earnings results for the second quarter of fiscal 2024.
Azenta, Inc. (Nasdaq: AZTA) reported financial results for Q2 fiscal 2024 with revenue of $159 million, up 7% YoY. Positive free cash flow for the fourth consecutive quarter. Strong organic revenue growth in Sample Management Solutions and B Medical Systems. Operating loss of $147 million, with operating margin at (92.3%). Non-GAAP diluted EPS improved to $0.05. Cash balance of $975 million. Share repurchase program ongoing. Lowered revenue guidance for FY2024 but raised earnings guidance.
Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings on May 8, 2024, after market close. The Company will hold a conference call and webcast to discuss financial results the same day at 4:30 p.m. Eastern Time. Analysts, investors, and media can access the live webcast on the Azenta website.
